One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four...read more
After two slow weeks, IPO pricing activity picked up with four companies raising a combined $466 million. Investors remain discerning despite the increased activity; a Cellectis spinoff and a mortgage REIT both priced below their midpoints, and a yoga studio...read more
PetIQ, which distributes and manufactures flea and tick, Rx and wellness products for dogs and cats, raised $100 million by offering 6.3 million shares at $16, the high end of the range of $14 to $16. The company originally filed to sell 5.67 million shares. The...read more
A diverse group of six deals are on the IPO calendar to raise nearly $1 billion in the week ahead. A few deals appear ready to launch, including online real estate broker...read more
US IPO Week Ahead: 1 SPAC on the calendar as August slowdown sets in
One blank check company, Capitol Investment Corp. IV, is on the IPO calendar for the week ahead to raise $350 million. The slowdown in IPO activity marks the start of the annual August lull. Aside from the one SPAC, there will likely be no IPOs for the next four...read more
US IPO Weekly Recap: Investors remain discerning amid increased activity
After two slow weeks, IPO pricing activity picked up with four companies raising a combined $466 million. Investors remain discerning despite the increased activity; a Cellectis spinoff and a mortgage REIT both priced below their midpoints, and a yoga studio...read more
PetIQ prices upsized IPO at $16, the high end of the range
PetIQ, which distributes and manufactures flea and tick, Rx and wellness products for dogs and cats, raised $100 million by offering 6.3 million shares at $16, the high end of the range of $14 to $16. The company originally filed to sell 5.67 million shares. The...read more
US IPO Week Ahead: Diverse 6-IPO week has yoga, pet meds and gene-edited crops
A diverse group of six deals are on the IPO calendar to raise nearly $1 billion in the week ahead. A few deals appear ready to launch, including online real estate broker...read more